Anna Gravelle, MSN, RN

Adjunct Professor

BC Children's Hospital
Cystic Fibrosis
Nurse Clinician
Rm. K3 - 189 Ambulatory Care Bldg.
4480 Oak Street
Vancouver, BC
Canada V6H 3V4

Profile
Publications

Selected Publications not Indexed in PubMed

Gravelle, A. M. & Davidson, A. G. F.  (2008).  Evaluation of "patient readiness" to Graduate from Pediatric to Adult Care.  Journal of Cystic Fibrosis, 7(Suppl 2), p.S99.

Gravelle, A. M. & Davidson, A. G. F.  (2008).  Progress in Cystic Fibrosis Transition Care in Canada.  Journal of Cystic Fibrosis, 7(Suppl 2), p.S100.

Gravelle, A. M. & Davidson, A. G. F.  (2007).  Cystic Fibrosis Adolescent Transition Care in Canada:  A Snapshot of Current Practice.  Pediatric Pulmonology, Suppl 30, p.410.

Lillquist, Y. P., Davidson, A. G. F., Jenkins, S., Gravelle, A., McIlwaine, M., Peacock, D., Kielska, A., & Henry, D.  (2007).  "Time to Event" Analysis of Efficacy of an Early Aggressive Eradication Protocol for First Growth Pseudomonas Aeruginosa in Cystic Fibrosis.  Pediatric Pulmonology, Suppl. 30, p. 310.

Gravelle, A., Guinet, L., Jenkins, S., Davidson, A.G.F., Cavallin, E., & Hopkins, J. (2006). Evaluation of a pilot Cystic Fibrosis “pre-graduation” clinic. Journal of Cystic Fibrosis, 5, Suppl 1, S87.

Davidson, A.G.F., Lillquist, Y.P., Jenkins, S., Gravelle, A., McIlwaine, M, Peacock, D., Ho, S., & Blondel-Hill, E. (2006). Economic effects of “first growth” therapy for Pseudomonas aeruginosa in Cystic Fibrosis patients – 1995-2005. Journal of Cystic Fibrosis, 5, Suppl 1, S21.

Davidson, A.G.F., Lillquist, Y., Gravelle, A., Jenkins, S., & McIlwaine, M. (2005). Pulmonary Function and Pseudomonas aeruginosa colonization in pediatric CF patients after aggressive treatment of Pseudomonas aeruginosa “First Growth”: 1995-2005. Journal of Cystic Fibrosis, Vol 4, suppl 1, S60.

Lillquist, Y.P., Davidson, A.G.F., Gravelle, A., Jenkins, S., Peacock, D., & McIlwaine, M. (2004). Pulmonary Function Outcome after Aggressive Intervention Protocol for First Growth Pseudomonas Aeruginosa: 9-year Experience, 1995-2004. Pediatric Pulmonology, Suppl 27, 290.

Speert D.Pl, Campbell, M.E., Henry, D.A., Milner, R., Taha, F., Gravelle, A., Davidson, A.G.F., Wong, L.T.K., & Mahenthiralingam, E. (2002). Epidemiology of Pseudomonas aeruginosa in Cystic Fibrosis in British Columbia, Canada. Am J Resp Crit Care Med, 166, 988-993.

Mahenthiralingam, E., Vandamme, P., Campbell, M., Henry, D., Gravelle, A., Wong, L.T.K., Davidson, A.G.F., Wilcox, P., Nakielna, B., & Speert, D.P. (2001). Infection with Burkholderia cepacia complex Genomovars in Patients with Cystic Fibrosis: Virulent Transmissible Strains of Genomovar III Can Replace Burkholderia multivorans. Clinical Infectious Diseases, 33, 1469-1475.

Lillquist, Y., Davidson, A.G.F., Gravelle, A., Wong, L.T.K., & Peacock, D. (2000). Results of Aggressive Treatment for “First Growth” Pseudomonas Aeruginosa in Cystic Fibrosis Patients. XIIIth International CF Congress (pp. 116). Stockholm, Sweden.

Gravelle, A., Wong, L.T.K., & Davidson, A.G.F. (1998). Home IV Therapy in Cystic Fibrosis Patients: Results from a Canadian National Survey. Pediatric Pulmonology, Supp, 17, 675.

Gravelle, A.M., Jenkins, S., Guinet, L., Lillquist, Y., & Davidson, A.G.F. (2004). Evaluation of an Adolescent Transition Care Clinical Pathway. Pediatric Pulmonology, Suppl 27, 364.

Davidson, A.G.F., Wong, L.T.K., Peacock, D., Jevon, G., Jamieson, D., Gravelle, A., & Schmidt, J. (June 1997). Liver Biopsy and Evaluation of Ursodeoxycholic Acid Therapy in Cystic Fibrosis. 21st European Cystic Fibrosis conference Davos, Switzerland.

Wong, L.T.K., Davidson, A.G.F., Jevon, G., Peacock, D., Gravelle, A., & Schmidt, J. (June 1996). Hepato-biliary Disease in Children with Cystic Fibrosis – a Clinical and Pathological Evaluation of the Effect of Ursodeoxycholic Acid Therapy. XIIth International CF Conference Jerusalem, Israel.

Wong, L.T.K., Davidson, A.G.F., Jevon, G., Jamieson, D., Peacock, D., Gravelle, A., & Schmidt, J. (1997). Hepato-Biliary Disease in Cystic Fibrosis: Enzymatic and Histopathologic Response to Ursodeoxycholic Acid Therapy. Pediatric Pulmonology, Supp 14, 356.

Davidson, A.G.F., Seear, M., Wong, L.T.K., Peacock, D., Gravelle, A., Schmidt, J., Menon, K., Cimolai, N., & Speert, D.P. (1997). Is the Acquisition of Pseudomonads in Cystic Fibrosis Patients Increased by use of Inhaled Corticosteroids? Unexpected Results from a Double Blind Placebo Controlled Study. Pediatric Pulmonology, Supp 14, 318.

Gravelle, A. M. (1997). Caring for a child with a progressive illness during the complex phase: Parents’ experience of facing adversity. Journal of Advanced Nursing, 25, 738-745.

Teaching